Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: A dose-guiding, tolerability, and safety study - Petersen, P; Grind, M; Adler, J (J Am Coll Cardiol, 2003)
et al.